The role of metabolic and haemodynamic factors in podocyte injury in diabetes.
about
New insights into the pathology of podocyte loss: mitotic catastropheHeart-type fatty acid binding protein is associated with proteinuria in obesity.Elevated circulating pigment epithelium-derived factor predicts the progression of diabetic nephropathy in patients with type 2 diabetesShear stress induces cell apoptosis via a c-Src-phospholipase D-mTOR signaling pathway in cultured podocytes.Apelin promotes diabetic nephropathy by inducing podocyte dysfunction via inhibiting proteasome activities.MiR-30a Inhibits the Epithelial--Mesenchymal Transition of Podocytes through Downregulation of NFATc3Adiponectin promotes functional recovery after podocyte ablation.Active ingredients of traditional Chinese medicine in the treatment of diabetes and diabetic complications.VEGF and podocytes in diabetic nephropathy.Signal transduction in podocytes--spotlight on receptor tyrosine kinases.Rethinking glomerular basement membrane thickening in diabetic nephropathy: adaptive or pathogenic?Advanced Glycation End Products: A Molecular Target for Vascular Complications in Diabetes.Albumin inhibits the insulin-mediated ACE2 increase in cultured podocytes.Growth arrest specific 2-like protein 1 expression is upregulated in podocytes through advanced glycation end-products.Modulation of APOL1-miR193a Axis Prevents Podocyte Dediffrentiation in High Glucose Milieu.Increased urine podocyte-associated messenger RNAs in severe obesity are evidence of podocyte injury.
P2860
Q26991667-61C55729-ED0D-4D90-B443-10C29098581DQ34429806-B6ACF45F-35D7-4292-BA06-7FB0950C7936Q34468107-9B3B5563-8AAB-41E1-9654-F114A3B701F5Q35936075-C706CEA1-233C-4D49-87AF-678A3C7D3661Q36057513-CCE2A915-680F-48EC-B551-5852C9EF909FQ36247357-69D6055F-CBE0-47D7-AAD1-BDE665B19E19Q36574746-DE2DAEF7-8F68-41FF-9964-CB15CB9C3CF9Q38031979-45861C85-9B56-468B-8164-FA1EE13377ECQ38041671-49A04104-5BA9-4162-AD30-7408F573ABA0Q38176169-461ED92F-33CD-4CF5-906F-A42EDF1949BEQ38942962-E75346AD-D934-4293-926D-BE60955535B2Q42115221-6A2999B4-827D-42A1-843E-92E9AF601EB7Q50475761-8B433677-D0CA-4FD7-827C-7D0F523E8EFEQ51496414-E9997CE4-3A00-4526-A02A-2A9DEB6DD20DQ52390909-16FC699E-F270-41CE-802F-9E9CC2DCD433Q53439401-68E5ED04-A431-4D07-9F9C-C5E57B4BD208
P2860
The role of metabolic and haemodynamic factors in podocyte injury in diabetes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The role of metabolic and haemodynamic factors in podocyte injury in diabetes.
@en
The role of metabolic and haemodynamic factors in podocyte injury in diabetes.
@nl
type
label
The role of metabolic and haemodynamic factors in podocyte injury in diabetes.
@en
The role of metabolic and haemodynamic factors in podocyte injury in diabetes.
@nl
prefLabel
The role of metabolic and haemodynamic factors in podocyte injury in diabetes.
@en
The role of metabolic and haemodynamic factors in podocyte injury in diabetes.
@nl
P2860
P356
P1476
The role of metabolic and haemodynamic factors in podocyte injury in diabetes.
@en
P2093
Kirstin Worthmann
Nicole Stieger
P2860
P304
P356
10.1002/DMRR.1164
P577
2011-03-01T00:00:00Z